Product
Atropine sulfate
Aliases
Eye drops, Low dose atropine sulfate, Low dose atropine sulfate eye drops, Lower dose atropine sulfate, Lower dose atropine sulfate eye drops
5 clinical trials
4 indications
Indication
MyopiaIndication
pharmacokineticsIndication
Cerebral PalsyIndication
SialorrheaClinical trial
A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops in Slowing the Progression of Myopia in ChildrenStatus: Active (not recruiting), Estimated PCD: 2023-08-20
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops in Slowing the Progression of Myopia in ChildrenStatus: Active (not recruiting), Estimated PCD: 2024-08-01
Clinical trial
A Randomized, Open-label Phase I Clinical Study to Evaluate the Systemic Pharmacokinetics and Safety of Atropine Sulfate Eye Drops in Healthy Chinese VolunteersStatus: Recruiting, Estimated PCD: 2023-06-01
Clinical trial
Single-Dose Pharmacokinetics of Atropine Oral Gel in Healthy AdultsStatus: Active (not recruiting), Estimated PCD: 2023-06-30
Clinical trial
The Use of Atropine 0.01% in the Prevention and Control of Myopia (ATOM3)Status: Active (not recruiting), Estimated PCD: 2025-12-31